Oncology Pharma (ONPH) Stock Analysis & Winston Score

Oncology Pharma Inc. is a small biotechnology company focused on developing cancer treatments. It works on drug candidates targeting various forms of cancer, with the goal of eventually selling approved therapies to hospitals, oncologists, and cancer patients. The company has no commercially approved products yet and remains in early-stage development.

Oncology Pharma does not currently generate meaningful revenue, which is typical for early-stage biotech firms that spend money on research before any product reaches the market. It operates primarily in the United States and has an extremely small market capitalization, meaning it has limited financial resources compared to larger pharmaceutical companies. The biggest risk the company faces is running out of cash before it can advance its drug candidates through clinical trials and regulatory approval, a challenge that affects many small biotechs at this stage.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

YoY Growth Rate

Revenue data limited

EPS Growth

YoY Growth Rate

EPS data limited

Insider Activity

44.4%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~1 months

$398 cash & investments

Short runway — potential dilution ahead through share issuance

Cash watch

Oncology Pharma has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

N/A

Data not available

Operating Margin

N/A

Data not available

ROCE

-0.0%

Weak — -0.0% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

-100.0%

Shrinking sales (-100.0% YoY)

EPS YoY

N/A

—

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

0.71

Moderate — manageable debt (0.71)

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/A

no trend

Data not available

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial